Articles tagged with Gut Microbiota
A study presented at the International Liver Congress 2012 suggests that gut microbiota transplantation can prevent the development of type 2 diabetes and non-alcoholic fatty liver disease. The study found that transplanting microbiota from healthy mice prevented insulin resistance and liver inflammation in germ-free mice.
The study reveals that gut microbiota modulates bile acid synthesis by altering the bile acid pool composition, reducing FXR inhibition in the small intestine.
A study by Caroline Karlsson found that rats fed a specific lactic acid bacteria HEAL19 had significantly less weight and inflammation compared to those without the bacteria. Additionally, babies born vaginally have lactobacilli in their gut flora as early as two days after birth.
Research reveals a strong association between nonalcoholic fatty liver disease (NAFLD) and both increased intestinal permeability and bacterial overgrowth in the small intestine. The study suggests that these factors contribute to the severity of steatosis, but not to more severe liver diseases like steatohepatitis or fibrosis.
A study found that treating cirrhotic patients with synbiotics or fermentable fiber can alter the gut flora, lowering ammonia levels and improving clinical signs of brain and liver dysfunction. The treatments were effective in reversing minimal hepatic encephalopathy in 50% of patients, compared to 13% in the placebo group.